PAVmed Inc. Research and Development Expense
PAVmed Inc. (PAVM) reported Research and Development Expense of $2.07 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-13
- PAVmed Inc. research and development expense for the quarter ending 2026-06-30 was $2.07M, a 161.65% increase year-over-year.
- PAVmed Inc. research and development expense for the quarter ending 2026-03-31 was $1.39M, a 76.37% increase year-over-year.
- PAVmed Inc. research and development expense for the quarter ending 2025-12-31 was $1.83M, a 126.52% increase year-over-year.
- PAVmed Inc. research and development expense for the quarter ending 2025-09-30 was $1.09M, a 29.44% decline year-over-year.
- PAVmed Inc. research and development expense for fiscal 2025 was $4.49M, a 24.28% decline from fiscal 2024.
- PAVmed Inc. research and development expense for fiscal 2024 was $5.93M, a 58.45% decline from fiscal 2023.
- PAVmed Inc. research and development expense for fiscal 2023 was $14.28M, a 43.66% decline from fiscal 2022.
- PAVmed Inc. research and development expense for fiscal 2022 was $25.34M, a 27.67% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.07M 10-Q · filed 2026-08-13 | $3.46M 10-Q · filed 2026-08-13 | $5.28M derived: sum of 3 quarters · filed 2026-08-13 | $6.37M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $1.39M 10-Q · filed 2026-05-14 | $3.22M derived: sum of 2 quarters · filed 2026-05-14 | $4.30M derived: sum of 3 quarters · filed 2026-05-14 | $5.09M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $1.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $2.92M derived: sum of 2 quarters · filed 2026-03-27 | $3.71M derived: sum of 3 quarters · filed 2026-08-13 | $4.49M 10-K · filed 2026-03-27 | ||||
| 2025-09-30 | $1.09M 10-Q · filed 2025-11-12 | $1.88M derived: sum of 2 quarters · filed 2026-08-13 | $2.66M 10-Q · filed 2025-11-12 | $3.47M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $790.00K 10-Q · filed 2026-08-13 | $1.58M 10-Q · filed 2026-08-13 | $2.38M derived: sum of 3 quarters · filed 2026-08-13 | $3.93M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $787.00K 10-Q · filed 2026-05-14 | $1.59M derived: sum of 2 quarters · filed 2026-05-14 | $3.14M derived: sum of 3 quarters · filed 2026-05-14 | $4.78M derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | $807.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $2.35M derived: sum of 2 quarters · filed 2026-03-27 | $3.99M derived: sum of 3 quarters · filed 2026-03-27 | $5.93M 10-K · filed 2026-03-27 | ||||
| 2024-09-30 | $1.54M 10-Q · filed 2025-11-12 | $3.18M derived: sum of 2 quarters · filed 2025-11-12 | $5.13M 10-Q · filed 2025-11-12 | $8.72M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $1.64M 10-Q · filed 2025-08-14 | $3.58M 10-Q · filed 2025-08-14 | $7.18M derived: sum of 3 quarters · filed 2025-08-14 | $10.34M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $1.94M 10-Q · filed 2025-05-15 | $5.54M derived: sum of 2 quarters · filed 2025-05-15 | $8.70M derived: sum of 3 quarters · filed 2025-05-15 | $12.17M derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | $3.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $6.76M derived: sum of 2 quarters · filed 2025-03-24 | $10.22M derived: sum of 3 quarters · filed 2025-03-24 | $14.28M 10-K · filed 2025-03-24 | ||||
| 2023-09-30 | $3.16M 10-Q · filed 2024-11-14 | $6.63M derived: sum of 2 quarters · filed 2024-11-14 | $10.68M 10-Q · filed 2024-11-14 | $17.35M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $3.47M 10-Q · filed 2024-08-12 | $7.52M 10-Q · filed 2024-08-12 | $7.91M 10-Q · filed 2023-08-14 | $14.19M derived: sum of 3 quarters · filed 2024-08-12 | $20.39M derived: sum of 4 quarters · filed 2024-08-12 | |||
| 2023-03-31 | $4.05M 10-Q · filed 2024-05-13 | $4.44M 10-Q · filed 2023-05-15 | $10.72M derived: sum of 2 quarters · filed 2024-05-13 | $16.93M derived: sum of 3 quarters · filed 2024-05-13 | $23.67M derived: sum of 4 quarters · filed 2024-05-13 | |||
| 2022-12-31 | $6.67M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $12.88M derived: sum of 2 quarters · filed 2024-03-25 | $19.62M derived: sum of 3 quarters · filed 2024-03-25 | $25.34M 10-K · filed 2024-03-25 | $25.55M 10-K · filed 2023-03-14 | |||
| 2022-09-30 | $6.20M 10-Q · filed 2023-11-13 | $12.94M derived: sum of 2 quarters · filed 2023-11-13 | $18.66M 10-Q · filed 2023-11-13 | $18.87M 10-Q · filed 2022-11-14 | $25.84M derived: sum of 4 quarters · filed 2023-11-13 | |||
| 2022-06-30 | $6.74M 10-Q · filed 2023-08-14 | $12.67M 10-Q · filed 2023-08-14 | $19.64M derived: sum of 3 quarters · filed 2023-08-14 | $24.95M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $5.93M 10-Q · filed 2023-05-15 | $12.90M derived: sum of 2 quarters · filed 2023-05-15 | $18.21M derived: sum of 3 quarters · filed 2023-05-15 | $22.46M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $6.97M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $12.27M derived: sum of 2 quarters · filed 2023-03-14 | $16.53M derived: sum of 3 quarters · filed 2023-03-14 | $19.85M 10-K · filed 2023-03-14 | ||||
| 2021-09-30 | $5.30M 10-Q · filed 2022-11-14 | $9.56M derived: sum of 2 quarters · filed 2022-11-14 | $12.88M 10-Q · filed 2022-11-14 | $16.52M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $4.26M 10-Q · filed 2022-08-15 | $7.57M 10-Q · filed 2022-08-15 | $11.21M derived: sum of 3 quarters · filed 2022-08-15 | $13.83M derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | $3.31M 10-Q · filed 2022-05-16 | $6.96M derived: sum of 2 quarters · filed 2022-05-16 | $9.58M derived: sum of 3 quarters · filed 2022-05-16 | $11.71M derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | $3.64M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-06 | $6.26M derived: sum of 2 quarters · filed 2022-04-06 | $8.39M derived: sum of 3 quarters · filed 2022-04-06 | $10.96M 10-K · filed 2022-04-06 | ||||
| 2020-09-30 | $2.62M 10-Q · filed 2021-11-22 | $4.75M derived: sum of 2 quarters · filed 2021-11-22 | $7.32M 10-Q · filed 2021-11-22 | $9.63M derived: sum of 4 quarters · filed 2021-11-22 | ||||
| 2020-06-30 | $2.13M 10-Q · filed 2021-08-16 | $4.70M 10-Q · filed 2021-08-16 | $7.01M derived: sum of 3 quarters · filed 2021-08-16 | $8.54M derived: sum of 4 quarters · filed 2021-08-16 | ||||
| 2020-03-31 | $2.63M 10-Q · filed 2021-05-17 | $4.88M derived: sum of 2 quarters · filed 2021-05-17 | $6.40M derived: sum of 3 quarters · filed 2021-05-17 | $7.81M derived: sum of 4 quarters · filed 2021-05-17 | ||||
| 2019-12-31 | $2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $3.77M derived: sum of 2 quarters · filed 2021-03-15 | $5.18M derived: sum of 3 quarters · filed 2021-03-15 | $6.63M 10-K · filed 2021-03-15 | $6.63M 10-K · filed 2020-04-14 | |||
| 2019-09-30 | $1.52M 10-Q · filed 2020-11-06 | $1.52M 10-Q · filed 2019-11-19 | $2.92M derived: sum of 2 quarters · filed 2020-11-06 | $4.38M 10-Q · filed 2020-11-06 | $4.38M 10-Q · filed 2019-11-19 | $5.74M derived: sum of 4 quarters · filed 2020-11-06 | ||
| 2019-06-30 | $1.41M 10-Q · filed 2020-08-14 | $1.41M 10-Q · filed 2019-08-14 | $2.86M 10-Q · filed 2020-08-14 | $2.86M 10-Q · filed 2019-08-14 | $4.22M derived: sum of 3 quarters · filed 2020-08-14 | $5.40M derived: sum of 4 quarters · filed 2020-08-14 | ||
| 2019-03-31 | $1.45M 10-Q · filed 2020-05-28 | $1.45M 10-Q · filed 2019-05-15 | $2.82M derived: sum of 2 quarters · filed 2020-05-28 | $3.99M derived: sum of 3 quarters · filed 2020-05-28 | $5.14M derived: sum of 4 quarters · filed 2020-05-28 | |||
| 2018-12-31 | $1.37M derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-14 | $2.54M derived: sum of 2 quarters · filed 2020-04-14 | $3.69M derived: sum of 3 quarters · filed 2020-04-14 | $4.25M 10-K · filed 2020-04-14 | ||||
| 2018-09-30 | $1.17M 10-Q · filed 2019-11-19 | $1.17M 10-Q · filed 2018-11-14 | $2.32M derived: sum of 2 quarters · filed 2019-11-19 | $2.88M 10-Q · filed 2019-11-19 | $2.88M 10-Q · filed 2018-11-14 | $3.44M derived: sum of 4 quarters · filed 2019-11-19 | ||
| 2018-06-30 | $1.15M 10-Q · filed 2019-08-14 | $1.15M 10-Q · filed 2018-08-13 | $1.71M 10-Q · filed 2019-08-14 | $1.71M 10-Q · filed 2018-08-13 | $2.27M derived: sum of 3 quarters · filed 2019-08-14 | $2.98M derived: sum of 4 quarters · filed 2019-08-14 | ||
| 2018-03-31 | $563.22K 10-Q · filed 2019-05-15 | $562.53K 10-Q · filed 2018-05-21 | $1.12M derived: sum of 2 quarters · filed 2019-05-15 | $1.83M derived: sum of 3 quarters · filed 2019-05-15 | $2.53M derived: sum of 4 quarters · filed 2019-05-15 | |||
| 2017-12-31 | $558.21K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $1.26M derived: sum of 2 quarters · filed 2019-04-01 | $1.96M derived: sum of 3 quarters · filed 2019-04-01 | $2.62M 10-K · filed 2019-04-01 | $2.62M 10-K · filed 2018-03-14 | |||
| 2017-09-30 | $704.87K 10-Q · filed 2018-11-14 | $1.41M derived: sum of 2 quarters · filed 2018-11-14 | $2.06M 10-Q · filed 2018-11-14 | $2.67M derived: sum of 4 quarters · filed 2018-11-14 | ||||
| 2017-06-30 | $701.74K 10-Q · filed 2018-08-13 | $1.36M 10-Q · filed 2018-08-13 | $1.97M derived: sum of 3 quarters · filed 2018-08-13 | $2.54M derived: sum of 4 quarters · filed 2018-08-13 | ||||
| 2017-03-31 | $656.71K 10-Q · filed 2018-05-21 | $1.26M derived: sum of 2 quarters · filed 2018-05-21 | $1.84M derived: sum of 3 quarters · filed 2018-05-21 | $2.20M derived: sum of 4 quarters · filed 2018-05-21 | ||||
| 2016-12-31 | $606.97K 10-K · filed 2017-02-16 | $1.19M derived: sum of 2 quarters · filed 2017-11-14 | $1.54M derived: sum of 3 quarters · filed 2017-11-14 | $1.72M 10-K · filed 2018-03-14 | ||||
| 2016-09-30 | $578.47K 10-K · filed 2017-02-16 | $933.48K derived: sum of 2 quarters · filed 2017-11-14 | $1.11M 10-Q · filed 2017-11-14 | $1.25M derived: sum of 4 quarters · filed 2017-11-14 | ||||
| 2016-06-30 | $355.00K 10-Q · filed 2017-08-11 | $534.14K 10-Q · filed 2017-08-11 | $675.49K derived: sum of 3 quarters · filed 2017-08-11 | $940.02K derived: sum of 4 quarters · filed 2017-08-11 | ||||
| 2016-03-31 | $179.14K 10-Q · filed 2017-05-22 | $320.49K derived: sum of 2 quarters · filed 2017-05-22 | $585.02K derived: sum of 3 quarters · filed 2017-05-22 | $652.47K derived: sum of 4 quarters · filed 2017-05-22 | ||||
| 2015-12-31 | $141.34K 10-K · filed 2017-02-16 | $405.88K derived: sum of 2 quarters · filed 2017-02-16 | $473.33K derived: sum of 3 quarters · filed 2017-02-16 | $489.33K 10-K · filed 2017-02-16 | ||||
| 2015-09-30 | $264.53K 10-K · filed 2017-02-16 | $331.98K derived: sum of 2 quarters · filed 2017-02-16 | $347.98K 10-Q · filed 2016-11-10 | |||||
| 2015-06-30 | $67.45K 10-K · filed 2017-02-16 | $83.45K 10-Q · filed 2016-08-12 | ||||||
| 2015-03-31 | $16.00K 10-K · filed 2017-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InspireMD, Inc. (NSPR) | $0.033B | ||
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |